EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Characterization and impact of non‐canonical WNT signaling on outcomes of urothelial carcinoma

Margaret Meagher, Harris Krause iD, Andrew Elliott, Alex Farrell iD, Emmanuel S Antonarakis, Bruno Bastos, Elisabeth I Heath, Christina Jamieson, Tyler F Stewart, Aditya Bagrodia, Chadi Nabhan, Matt Oberley und 2 weitere

Cancer Medicine · 2024

DOI: 10.1002/cam4.7148 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Margaret Meagher und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, UC San Diego School of Medicine, La Jolla, California, USA. Hauptthemen laut MEDLINE: Carcinoma, Transitional Cell, Urinary Bladder Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Non‐canonical WNT family (WNT5A pathway) signaling via WNT5A through ROR1 and its partner, ROR2 , or Frizzled2 ( FZD2 ) is linked to processes driving tumorigenesis and therapy resistance. We utilized a large dataset of urothelial carcinoma (UC) tumors to characterize non‐canonical WNT signaling through WNT5A , ROR1 , ROR2 , or FZD2 expression.

Methods

NextGen Sequencing of DNA (592 genes or WES)/RNA (WTS) was performed for 4125 UC tumors submitted to Caris Life Sciences. High and low expression of WNT5A , ROR1 , ROR2 , and FZD2 was defined as ≥ top and

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Transitional CellUrinary Bladder NeoplasmsHumansWnt ProteinsWnt Signaling PathwayReceptor Tyrosine Kinase-like Orphan ReceptorsWnt-5a Protein

Stichwörter der Autor:innen

FZD2Non‐canonicalRORUrothelial carcinomaWNT signalingWNT5A

Substanzen

Wnt ProteinsReceptor Tyrosine Kinase-like Orphan ReceptorsWnt-5a Protein

Autor:innen und Institutionen

  • Department of Urology, UC San Diego School of Medicine, La Jolla, California, USA.
  • Caris Life Sciences, Phoenix, Arizona, USA.
  • Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minnesota, USA.
  • Miami Cancer Institute, Miami, Florida, USA.
  • Karmanos Cancer Institute, Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan, USA.
  • Department of Medicine, UC San Diego School of Medicine, La Jolla, California, USA.

ORCID-Profile: Harris Krause, Alex Farrell, Rana R McKay, Amirali Salmasi

Zitieren

APA

Meagher, M., Krause, H., Elliott, A., Farrell, A., Antonarakis, E. S., Bastos, B., Heath, E. I., Jamieson, C., Stewart, T. F., Bagrodia, A., Nabhan, C., Oberley, M., McKay, R. R., & Salmasi, A. (2024). Characterization and impact of non‐canonical WNT signaling on outcomes of urothelial carcinoma. Cancer Medicine. https://doi.org/10.1002/cam4.7148

Vancouver

Meagher M, Krause H, Elliott A, Farrell A, Antonarakis ES, Bastos B, et al. Characterization and impact of non‐canonical WNT signaling on outcomes of urothelial carcinoma. Cancer Medicine. 2024. doi:10.1002/cam4.7148

BibTeX
@article{Meagher2024,
  author = {Meagher, Margaret and Krause, Harris and Elliott, Andrew and Farrell, Alex and Antonarakis, Emmanuel S and Bastos, Bruno and Heath, Elisabeth I and Jamieson, Christina and Stewart, Tyler F and Bagrodia, Aditya and Nabhan, Chadi and Oberley, Matt and McKay, Rana R and Salmasi, Amirali},
  title = {Characterization and impact of non‐canonical WNT signaling on outcomes of urothelial carcinoma},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.7148}
}
Kostenlos starten →